- Adults (18-64 years)
- People at high risk of STIs
- PrEP users
- People living with HIV
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Blood sample
- Pharmacological intervention
- Vaccination
- JYNNEOS
Population: People living with HIV
Individuals who have been diagnosed with human immunodeficiency virus (HIV) and may be receiving antiretroviral therapy to manage the condition
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- People at high risk of STIs
- Men who have sex with men
- People living with HIV
- Hospital
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- PrEP users
- People living with HIV
- Hospital
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- People at high risk of STIs
- People living with HIV
- Hospital
- Infectious diseases unit
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- PrEP users
- People living with HIV
- Non-hospital health centre
- Telemedicine
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- PrEP users
- People living with HIV
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- Men who have sex with men
- People living with HIV
- Hospital
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- Fragile population
- Immunocompromised host
- People living with HIV
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- Fragile population
- PrEP users
- People living with HIV
- Hospital
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN